Back to School: How biopharma can reboot drug development. Access exclusive analysis here
On Dec. 26, 2012, NovaDel said it granted Suda an option to acquire NovaMist sublingual delivery technology and other products.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury